CA532132A - 3.beta.,20-DIACYLOXY-17,20-EPOXY-11 KETOALLOPREGNANE - Google Patents

3.beta.,20-DIACYLOXY-17,20-EPOXY-11 KETOALLOPREGNANE

Info

Publication number
CA532132A
CA532132A CA532132A CA532132DA CA532132A CA 532132 A CA532132 A CA 532132A CA 532132 A CA532132 A CA 532132A CA 532132D A CA532132D A CA 532132DA CA 532132 A CA532132 A CA 532132A
Authority
CA
Canada
Prior art keywords
ketoallopregnane
diacyloxy
beta
epoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA532132A
Other languages
English (en)
Inventor
Walker Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Publication date
Application granted granted Critical
Publication of CA532132A publication Critical patent/CA532132A/fr
Expired legal-status Critical Current

Links

CA532132A 3.beta.,20-DIACYLOXY-17,20-EPOXY-11 KETOALLOPREGNANE Expired CA532132A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA532132T

Publications (1)

Publication Number Publication Date
CA532132A true CA532132A (fr) 1956-10-23

Family

ID=35686742

Family Applications (1)

Application Number Title Priority Date Filing Date
CA532132A Expired CA532132A (fr) 3.beta.,20-DIACYLOXY-17,20-EPOXY-11 KETOALLOPREGNANE

Country Status (1)

Country Link
CA (1) CA532132A (fr)

Similar Documents

Publication Publication Date Title
CA527462A (fr) 1-polyhalogeno-3,4-epoxybutanes
CA532132A (fr) 3.beta.,20-DIACYLOXY-17,20-EPOXY-11 KETOALLOPREGNANE
CA534637A (fr) PREPARATION DE 3.beta.-ACYLOXY-11,20-DICETOALLOPREGNANE
CA527550A (fr) 3.beta.,11.alpha.-DIHYDROXYALLOPREGNANE-20-ONE
CA528609A (fr) 4-pregnene-3,6,11,20-tetraone
CA551091A (fr) 11.beta.-HYDROXYPROGESTERONE 3,20-DICETALS
CA534902A (fr) .beta.-HALOETHYLECYCLOHEXENES
CA529033A (fr) MONOACETATE D'ALLOPRENANE-3.beta., 11.alpha., 17.alpha., 21-TETROL-20-ONE-21
CA528614A (fr) 3.beta.,11.alpha.-DIHYDROXY-5-PREGNENE-7,20-DIONE
CA528934A (fr) 3,11-dihydroxy-16-pregnene-20-one
CA530054A (fr) 2,4-diamino-5-benzylepyrimidines
CA524985A (fr) 3,3,3-nitrilotrispropanamide
CA528619A (fr) 21-acyloxy-4-pregnene-3-6,20-triones
CA527663A (fr) 3.alpha.-ACYLOXY-11,20-DICETO-21,21-DIHYDROXY-12.alpha.-HALO-17.alpha.-BROMOPREGNENE
CA527662A (fr) 3.alpha.ACYLOXY-21,21-DIHYDROXY-11-20-DICETO-12.alpha.-BROMOPREGNENE
CA508896A (fr) 11 .beta.-HYDROXYPREGNANE-3,20-DIONE-3,20-DICETALS
CA528935A (fr) 3,11.alpha., 20-TRIACYLOXY-3,17(2)-PREGNADIENES
CA531574A (fr) 9 (11),16-bisdehydro-21-norprogesterone
CA523319A (fr) .delta.5,7-sapogenines
CA557779A (fr) 3-CETO-11.beta.-HYDROXY-4,17(20)-PREGNADIENE-21-AL
CA534295A (fr) Composes de 1,8-dihydroxy-5-nitro-4-anilinoanthraquinone
CA528532A (fr) Composes de dodecahydrophenanthrene-1,4,7-trione
CA526197A (fr) Composes de 1,5-dihydroxy-8-halo-4-aminoanthraquinone
CA568740A (fr) 11.beta.,21-DIHYDROXY-3,20-DICETO-4-PREGNENE-18-AL
CA535040A (fr) D,l-dihydro-nor-lysergyle-glycinamide